CYP7B1 and metabolic dysfunction-associated steatohepatitis: However, murine knockouts of CH25H, EBI2 and CYP7B1 neither effected liver function tests, nor liver inflammatory markers, histological NAFLD activity or liver fibrosis in a long-term feeding model of NASH [31].